Atos: Tech Foundations’ turnover will reach a low in 2024

Atos: Tech Foundations’ turnover will reach a low in 2024

by Mathieu Rosemain PARIS (Reuters) – IT consultancy Atos, which plans to split into two publicly traded entities, said on…
Market: Caution dominates on European markets

Market: Caution dominates on European markets

(News Bulletin 247) – Morose atmosphere on the main stock markets of Europe: if London is stable, Paris and Frankfurt…
Europe: Europe in decline, expectations around central banks dominate

Europe: Europe in decline, expectations around central banks dominate

PARIS (Reuters) – The main European stock markets are on the decline on Wednesday morning in a context of questions…
Atos: Ahead of its recovery plan, Atos more optimistic for its historical businesses

Atos: Ahead of its recovery plan, Atos more optimistic for its historical businesses

(News Bulletin 247) – The digital services company, which is preparing to split into two in the second half, has…
Market: Caution dominates on European markets

Sword group: Stifel maintains its positive opinion

(News Bulletin 247) – Stifel maintains its Buy recommendation on Sword Group shares and its price target at 60E. The…
Market: Ten days after the elections in Turkey, the Turkish lira has never been so weak against the dollar

Market: Ten days after the elections in Turkey, the Turkish lira has never been so weak against the dollar

(News Bulletin 247) – The Turkish currency sank a new historic low against the dollar on Wednesday, ten days after…
Market: Caution dominates on European markets

BMW signs €8 billion credit facility

(News Bulletin 247) – BMW Group has signed an €8.0 billion syndicated revolving credit facility (RCF) with a five-year term…
Market: Caution dominates on European markets

Euroapi: Increased investments on the Budapest site

(News Bulletin 247) – Euroapi plans to invest 50 million euros on its Budapest site in order to meet the…
Market: Caution dominates on European markets

Remy Cointreau: Credit Suisse lowers its price target

(News Bulletin 247) – Credit Suisse retains its Underperformance rating on Rémy Cointreau shares with a price target lowered to…
Theranexus: After the United States, Europe authorizes Theranexus to launch its last phase of clinical trials

Theranexus: After the United States, Europe authorizes Theranexus to launch its last phase of clinical trials

(News Bulletin 247) – The biopharmaceutical company has obtained the green light from the European Medicines Agency on the design…